Vaccines for the Prevention of Melioidosis and Glanders

Vaccines for the Prevention of Melioidosis and Glanders Curr Trop Med Rep (2017) 4:136–145 DOI 10.1007/s40475-017-0121-7 MELIOIDOSIS AND TROPICAL BACTERIOLOGY (A TORRES, SECTION EDITOR) 1 1 Monica M. Johnson & Kristy M. Ainslie Published online: 14 July 2017 Springer International Publishing AG 2017 Abstract mallei, the causative agent of glanders, are aerobic, gram-neg- Purpose of Review Burkholderia pseudomallei’sand ative, motile bacilli classified by the US Centers for Disease Burkholderia mallei’s high rate of infectivity, limited treat- Control and Prevention (CDC) as tier 1 select agents due to ment options, and potential use as biological warfare agents high virulence when inhaled and potential to cause large-scale underscore the need for development of effective vaccines illness if disseminated. Additionally, Burkholderia spp. against these bacteria. Research efforts focused on vaccines have resistance to a wide range of antibiotics, including against these bacteria are in preclinical stages, with no ap- penicillin [2, 3], which adds additional concern surround- proved formulations currently on the market. ing the bacteria. Research efforts over the last decade Recent Findings Several live attenuated and subunit vaccine have evaluated prophylactic and therapeutic treatment formulations have been evaluated in animal studies, with no options to combat these emerging infectious diseases; reports of significant long-term survival after lethal challenge. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Tropical Medicine Reports Springer Journals

Vaccines for the Prevention of Melioidosis and Glanders

Loading next page...
 
/lp/springer_journal/vaccines-for-the-prevention-of-melioidosis-and-glanders-h4Rv4mSNW9
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Tropical Medicine; Parasitology; Behavioral Sciences; Infectious Diseases
eISSN
2196-3045
D.O.I.
10.1007/s40475-017-0121-7
Publisher site
See Article on Publisher Site

Abstract

Curr Trop Med Rep (2017) 4:136–145 DOI 10.1007/s40475-017-0121-7 MELIOIDOSIS AND TROPICAL BACTERIOLOGY (A TORRES, SECTION EDITOR) 1 1 Monica M. Johnson & Kristy M. Ainslie Published online: 14 July 2017 Springer International Publishing AG 2017 Abstract mallei, the causative agent of glanders, are aerobic, gram-neg- Purpose of Review Burkholderia pseudomallei’sand ative, motile bacilli classified by the US Centers for Disease Burkholderia mallei’s high rate of infectivity, limited treat- Control and Prevention (CDC) as tier 1 select agents due to ment options, and potential use as biological warfare agents high virulence when inhaled and potential to cause large-scale underscore the need for development of effective vaccines illness if disseminated. Additionally, Burkholderia spp. against these bacteria. Research efforts focused on vaccines have resistance to a wide range of antibiotics, including against these bacteria are in preclinical stages, with no ap- penicillin [2, 3], which adds additional concern surround- proved formulations currently on the market. ing the bacteria. Research efforts over the last decade Recent Findings Several live attenuated and subunit vaccine have evaluated prophylactic and therapeutic treatment formulations have been evaluated in animal studies, with no options to combat these emerging infectious diseases; reports of significant long-term survival after lethal challenge.

Journal

Current Tropical Medicine ReportsSpringer Journals

Published: Jul 14, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off